Kevin Bitterman is a partner at Atlas Venture who creates and invests in companies developing new medicines. He previously invested at Polaris Partners and was the founding CEO of Editas Medicine, Morphic Therapeutic and Visterra.
Kevin Bitterman is a partner at Atlas Venture who creates and invests in companies developing new medicines. He previously invested at Polaris Partners and was the founding CEO of Editas Medicine, Morphic Therapeutic and Visterra.
Career
Partner at Atlas Venture until Present